You can buy or sell T2 Biosystems and other stocks, options, ETFs, and crypto commission-free!
T2 Biosystems, Inc. engages in the development of proprietary technology platform. It offers the T2 Magnetic Resonance technology which enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types. Read More It products include T2Bacteria Panel, T2Candida Panel, T2Dx Instrument, AND T2MR Technology. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.
52 Week High
52 Week Low
Yahoo FinanceMay 13
T2 Biosystems Reports Granting of Inducement Awards
LEXINGTON, Mass., May 13, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that on May 8, 2019 it issued inducement awards to three new employees. These awards were made under T2 Biosystems’ Inducement Award Plan (the "Inducement Plan"), which was adopted by the company’s Board of Directors on March 1, 2018 and amended and restated on February 21, 2019 an...
Seeking AlphaMay 3
T2 Biosystems, Inc. (TTOO) CEO John McDonough on Q1 2019 Results - Earnings Call Transcript
T2 Biosystems, Inc. (NASDAQ:TTOO) Q1 2019 Earnings Conference Call May 2, 2019 4:30 PM ET Company Participants Zack Kubow - W2O Group John McDonough - CEO, President & Director John Sprague - CFO & SVP Thomas Lowery - Chief Scientific Officer Conference Call Participants Jordan Abrams - Cantor Fitzgerald & Co. Mark Massaro - Canaccord Genuity Limited Stephen Brozak - WBB Securities Casey Woodring - Janney Yi Chen - H.C. Wainwright & Co. Soumit Roy - JonesTrading Institutional Services Operator ...
Expected Aug 1, After Hours